The USFDA in its ‘Global update Newsletter’ from its Office of Global Policy and Strategy (OGPS), issued in February 2024 said “officers of the Drugs Control Administration, Telangana, have joined the group of eligible states to observe inspections conducted by the USFDA in India”.
